(Q37027309)

17 August 2017

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy (English)

1 reference

17 August 2017

0 references

0 references

1 reference

1 reference

1 reference

1

Babafemi Taiwo

1 reference

17 August 2017

10

Joseph J Eron

1 reference

17 August 2017

8

Daniel R Kuritzkes

1 reference

17 August 2017

Roy M Matining

2

1 reference

17 August 2017

Lu Zheng

3

1 reference

17 August 2017

Michael M Lederman

4

1 reference

17 August 2017

Charles R Rinaldo

5

1 reference

17 August 2017

Peter S Kim

6

1 reference

17 August 2017

Baiba I Berzins

7

1 reference

17 August 2017

Amy Jennings

9

1 reference

17 August 2017

Cara C Wilson

11

1 reference

17 August 2017

language of work or name

English

0 references

publication date

18 April 2013

1 reference

Journal of Antimicrobial Chemotherapy

17 August 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 August 2017

68

1 reference

17 August 2017

8

1 reference

17 August 2017

1857-1861

1 reference

Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Plasma levels of soluble CD14 independently predict mortality in HIV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716396

The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23599363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23599363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JAC/DKT120

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23599363

1 reference